KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Return on Equity (2016 - 2025)

Historic Return on Equity for Novartis Ag (NVS) over the last 7 years, with Q1 2025 value amounting to 0.66%.

  • Novartis Ag's Return on Equity changed N/A to 0.66% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.66%, marking a year-over-year change of. This contributed to the annual value of 0.31% for FY2025, which is 500.0% up from last year.
  • According to the latest figures from Q1 2025, Novartis Ag's Return on Equity is 0.66%.
  • In the past 5 years, Novartis Ag's Return on Equity registered a high of 11.97% during Q2 2021, and its lowest value of 0.09% during Q1 2023.
  • Over the past 4 years, Novartis Ag's median Return on Equity value was 0.68% (recorded in 2023), while the average stood at 2.42%.
  • Per our database at Business Quant, Novartis Ag's Return on Equity soared by 4300bps in 2022 and then tumbled by -6800bps in 2023.
  • Over the past 4 years, Novartis Ag's Return on Equity (Quarter) stood at 11.97% in 2021, then crashed by -94bps to 0.77% in 2022, then dropped by -9bps to 0.7% in 2023, then dropped by -5bps to 0.66% in 2025.
  • Its Return on Equity was 0.66% in Q1 2025, compared to 0.7% in Q2 2023 and 0.09% in Q1 2023.